Skip to main content
Swedish Orphan Biovitrum logo

Swedish Orphan Biovitrum — Investor Relations & Filings

Ticker · SOBI ISIN · SE0000872095 LEI · 549300124Y3MQI87PT35 ST Manufacturing
Open in API
Filings indexed 892 across all filing types
Latest filing 2012-03-30 Legal Proceedings Report
Country SE Sweden
Listing ST SOBI

About Swedish Orphan Biovitrum

https://www.sobi.com/en

Swedish Orphan Biovitrum (Sobi) is a specialized biopharmaceutical company dedicated to developing and delivering innovative treatments for rare and debilitating diseases. The company's primary focus is on the therapeutic areas of haematology and immunology, with a significant legacy and continued leadership in haemophilia care. Sobi addresses the high unmet medical needs of patients by advancing a pipeline of innovative medicines and working to expand patient access globally. The company's mission is to transform the lives of people affected by rare conditions through dedicated research, development, and global collaboration.

Recent filings

Filing Released Lang Actions
Sobi amends its agreement with sellers of Arexis AB
Legal Proceedings Report Classification · 99% confidence The document announces an amendment to a share purchase agreement related to a past acquisition (Arexis AB) and details a resulting payment structure to remove future milestone obligations. This involves changes to financing/capital structure (SEK 77 M payment, allocation to intangible assets, charge against operating income) and the resolution of legal/arbitration proceedings. Since the core event is a significant financial transaction related to an acquisition settlement and the removal of future financial obligations, it best fits the Capital/Financing Update category (CAP). It is not a standard earnings release (ER), interim report (IR), or a general regulatory filing (RNS), as it describes a specific, material financial transaction.
2012-03-30 English
Kallelse till årsstämma i Swedish Orphan Biovitrum AB (publ)
AGM Information Classification · 99% confidence The document is titled "Kallelse till årsstämma i Swedish Orphan Biovitrum AB (publ)" which translates to "Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)". It details the date, time, location, registration procedures, and a detailed agenda (Förslag till dagordning) for the meeting, including proposals for board elections, remuneration, and incentive programs. This content is characteristic of a formal notice and materials distributed for an Annual General Meeting (AGM). The specific code for AGM materials is AGM-R.
2012-03-26 Swedish
Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)
AGM Information Classification · 100% confidence The document is explicitly titled "Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)". It details the date, time, location, participation requirements, proxy rules, and a detailed proposed agenda for a general meeting. The agenda items (e.g., election of chairman, approval of financial statements, determination of fees, election of directors/auditor) are characteristic of an Annual General Meeting (AGM). Therefore, the classification should be AGM-R (AGM Information).
2012-03-26 English
Ekonomi- och finansdirektör Lars Sandström lämnar Sobi
Board/Management Information Classification · 99% confidence The document text is a short announcement dated March 20, 2012, stating that the Chief Financial Officer (Ekonomi- och finansdirektör), Lars Sandström, is leaving the company (Sobi) and that recruitment for a successor has begun. This directly concerns a change in senior management. Based on the definitions, this aligns perfectly with the 'Board/Management Information' category. Filing Type Code: MANG. The document is short and contains the core announcement, not an announcement *about* a report, so RPA/RNS is not the primary fit.
2012-03-20 Swedish
CFO Lars Sandström to leave Sobi
Board/Management Information Classification · 99% confidence The document is a short announcement dated March 20, 2012, stating that the CFO, Lars Sandström, will be leaving the company (Sobi) during the summer of 2012. It includes a quote from the CEO and contact information. This content directly relates to a change in senior management personnel. Based on the definitions, this fits the 'Board/Management Information' category (MANG). The document length is very short (1350 chars), but it is the primary announcement itself, not an announcement *about* another report, so the RPA/RNS rule does not apply here.
2012-03-20 English
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the fourth quarter and full year 2011 for the company Sobi. It contains detailed financial statements, including income statements, revenue analysis, balance sheet items, and management commentary on performance. It is not an announcement of a report, but the report itself, and it covers a period shorter than a full fiscal year (quarterly) and the full year, fitting the definition of an Interim/Quarterly Report. Q4 2011
2012-02-23 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.